METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to slow advanced esophageal cancer
Disease control OngoingThis study tested if adding an experimental drug called cixutumumab to standard chemotherapy (paclitaxel) could better control cancer that had spread or returned. It involved 94 adults with advanced esophageal or gastroesophageal junction cancer whose initial treatment had stoppe…
Matched conditions: METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 02:20 UTC
-
Major trial tests Triple-Threat attack on deadly esophageal cancer
Disease control OngoingThis large, late-stage study is testing whether adding the drug lenvatinib to a standard immunotherapy and chemotherapy combination helps people with advanced esophageal cancer that has spread. The main goal is to see if this three-drug approach helps patients live longer compare…
Matched conditions: METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC